Summary
The Federal Circuit affirmed the district court's dismissal without prejudice of a declaratory judgment action seeking a declaration that Medtronic did not breach a patent royalty agreement because the patents lacked valid claim coverage. The court held that the district court did not abuse its discretion in abstaining under the Wilton/Brillhart doctrine in favor of a concurrent state court contract action, even though the federal complaint raised substantial questions of patent validity and claim scope within the exclusive jurisdiction of the federal courts. The Federal Circuit concluded that the district court's exercise of discretion was reasonable given the ongoing state court proceedings and the availability of federal review after the state court's resolution.
Topics
Practice areas
Questions Presented
- Whether the district court had subject matter jurisdiction over the declaratory judgment action under 28 U.S.C. § 1338, i.e., whether the action 'arises under' federal patent law.
- Whether the district court abused its discretion in dismissing the declaratory judgment action without prejudice under the Wilton/Brillhart abstention doctrine in light of the concurrent state court proceedings.
Holdings
- The declaratory judgment action arises under federal patent law because the issues of patent validity and claim scope are necessarily raised, actually disputed, substantial, and capable of resolution in federal court without disrupting the federal-state balance, thus the district court had jurisdiction.
- The district court did not abuse its discretion in dismissing the declaratory judgment action without prejudice because the state court had already tried the case and the matter was on appeal, and the federal court acted within its discretion to avoid duplicative litigation and respect the concurrent state proceeding.
Key quotations
“Here, there is no purpose to be served by the declaratory judgment Medtronic seeks, at least at this time. Medtronic is asking for a declaratory judgment that it did not breach the Facet Screw Agreement and does not owe Dr. Sasso any damages. But the state court has already entered judgment in Dr. Sasso's favor on that claim. No order or judgment of this Court can undo that judgment—only the Indiana courts of appeals and the United States Supreme Court have authority to review that judgment.” (at 6)
“Applying the standards of precedent, the issues of validity and claim scope are well-pleaded in this declaratory complaint, are actually disputed, are substantial to the federal system as a whole, and the federal-state judicial balance would not be disrupted by the district court's exercise of declaratory jurisdiction. Thus, this declaratory action is within the district court's jurisdictional authority, and we have jurisdiction to receive this appeal and to determine whether the district court abused its discretion in abstaining from exercise of declaratory jurisdiction.” (at 9-10)
“On the entirety of the circumstances, we conclude that the district court exercised 'common-sense accommodation of judgment,' id., and did not abuse its discretion in abstaining and dismissing without prejudice.” (at 15)
Factual background
Medtronic and Dr. Sasso entered into a Purchase Agreement (Facet Screw Agreement) on December 1, 1999, under which Medtronic agreed to pay royalties on sales of medical devices covered by valid claims of U.S. Patent Nos. 6,287,313 and 6,562,046. Medtronic paid royalties from 2002 to 2018. In 2014, Dr. Sasso filed a state court breach of contract action in Indiana, alleging that Medtronic was not paying royalties on all relevant devices. The state court granted summary judgment on the term of the agreement, ruling that patent validity was irrelevant to the payment obligation, and excluded evidence of invalidity at trial. The jury found Medtronic breached and awarded damages. Medtronic appealed to the Indiana Court of Appeals. Meanwhile, Medtronic filed a federal declaratory judgment action seeking a declaration of no breach, arguing that the patents' claims as construed to cover the additional devices were invalid. The PTO reexamined the patents and cancelled the relevant claims. The district court dismissed the federal action without prejudice, citing the state court proceedings and the lack of purpose for declaratory relief at that time.
Procedural history
Medtronic filed a declaratory judgment action in the Northern District of Indiana seeking a declaration that it did not breach the Facet Screw Agreement because the patents-in-suit were invalid. The district court dismissed the action without prejudice, applying the Wilton/Brillhart abstention doctrine in light of a concurrent state court action in Marshall Circuit Court, Indiana, between the same parties. The state court had already entered judgment against Medtronic, which was on appeal to the Indiana Court of Appeals. Medtronic appealed the dismissal to the Federal Circuit.